A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Needle, MD
Cybrexa Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Honor Health
Scottsdale, Arizona, United States
Withdrawn - Arizona Oncology Associates
Tucson, Arizona, United States
Active, not recruiting - Usc Norris Comprehensive Cancer Center
Los Angeles, California, United States
Active, not recruiting - Yale University School of Medicine
New Haven, Connecticut, United States
Active, not recruiting - D&h Cancer Research Center
Margate, Florida, United States
Active, not recruiting - South Florida Gynecology
Tampa, Florida, United States
Active, not recruiting - Northwest Cancer Centers
Dyer, Indiana, United States
Withdrawn - Norton Cancer Institute
Louisville, Kentucky, United States
Active, not recruiting - Women'S Cancer Care
Covington, Louisiana, United States
Active, not recruiting - Albert Einstein College of Medicine Montefiore Medical
New York, New York, United States
Active, not recruiting - Pci Nyu Langone Health
New York, New York, United States
Active, not recruiting - University Hospitals Seidman Cancer Center
Cleveland, Ohio, United States
Active, not recruiting - Oncology Associates of Oregon
Eugene, Oregon, United States
Active, not recruiting - Allegheny Singer Research Institute D/b/a Ahn Research Institution
Pittsburgh, Pennsylvania, United States
Recruiting - Mary Crowley Cancer Research
Dallas, Texas, United States
Recruiting - Texas Oncology- Gulf Coast
The Woodlands, Texas, United States
Active, not recruiting - Multicare Institute for Research & Innovation
Tacoma, Washington, United States
Active, not recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Sept 2024
- Primary completion
- 31 Oct 2025
- Completion
- 31 Oct 2025
- Last update posted
- 6 Oct 2025
- Registered enrollment
- 40
- Registry id
- NCT06315491
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.